We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$243M
AUM Growth
-$8.83M
Cap. Flow
-$21M
Cap. Flow %
-8.67%
Top 10 Hldgs %
68.56%
Holding
127
New
18
Increased
18
Reduced
12
Closed
20

Top Buys

Rank Stock Value
1
CLMT icon
Calumet Specialty Products
CLMT
+$6.99M
2
FTAI icon
FTAI Aviation
FTAI
+$4.2M
3
UPLD icon
Upland Software
UPLD
+$4.19M
4
SWBI icon
Smith & Wesson
SWBI
+$3.62M
5
META icon
Meta Platforms (Facebook)
META
+$3.59M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$33.3M
2
PFE icon
Pfizer
PFE
+$12.4M
3
MSFT icon
Microsoft
MSFT
+$6.16M
4
RXDX
Ignyta, Inc.
RXDX
+$1.81M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$1.3M

Sector Composition

Rank Sector Weight
1 Healthcare 55.53%
2 Technology 8.11%
3 Industrials 7.13%
4 Financials 7.01%
5 Energy 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
76
Bristol-Myers Squibb
BMY
$136B
$141K 0.06%
2,225
– –
MSFT icon
77
Microsoft
MSFT
$3.81T
$128K 0.05%
1,400
-67,350
-98% -$6.16M
FNB icon
78
FNB Corp
FNB
$6.55B
$120K 0.05%
8,905
– –
ORIT
79
DELISTED
Oritani Financial Corp. New
ORIT
$120K 0.05%
7,800
– –
CUZ icon
80
Cousins Properties
CUZ
$4.85B
$117K 0.05%
3,357
– –
ABEO icon
81
Abeona Therapeutics
ABEO
$339M
$101K 0.04%
+281
New +$104K
TPST icon
82
Tempest Therapeutics
TPST
$17.5M
$91K 0.04%
38
– –
MBAI
83
Check-Cap
MBAI
$9.05M
$84K 0.03%
97
– –
MDT icon
84
Medtronic
MDT
$117B
$84K 0.03%
1,050
– –
CC icon
85
Chemours
CC
$2.35B
$66K 0.03%
1,360
– –
F icon
86
Ford
F
$55.3B
$55K 0.02%
5,000
– –
AFMD
87
DELISTED
Affimed
AFMD
$44K 0.02%
+2,400
New +$45.3K
AEHL icon
88
Antelope Enterprise Holdings
AEHL
$4.02M
– –
0
– –
EDIT icon
89
Editas Medicine
EDIT
$485M
$33K 0.01%
+1,000
New +$35.6K
ALNY icon
90
Alnylam Pharmaceuticals
ALNY
$31.7B
$30K 0.01%
249
– –
LITS
91
Lite Strategy Inc
LITS
$33.4M
$29K 0.01%
700
– –
PBCT
92
DELISTED
People's United Financial Inc
PBCT
$28K 0.01%
1,500
– –
BNS icon
93
Scotiabank
BNS
$113B
$25K 0.01%
400
– –
EXP icon
94
Eagle Materials
EXP
$6.06B
$23K 0.01%
228
– –
LLY icon
95
Eli Lilly
LLY
$1.05T
$23K 0.01%
300
– –
ABLX
96
DELISTED
Ablynx NV
ABLX
$11K ﹤0.01%
+200
New +$9.91K
DBRG icon
97
DigitalBridge
DBRG
$2.99B
$8K ﹤0.01%
367
– –
STWD icon
98
Starwood Property Trust
STWD
$5.85B
$8K ﹤0.01%
400
– –
AMLP icon
99
Alerian MLP ETF
AMLP
$13.4B
$6K ﹤0.01%
120
– –
SCU
100
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$5K ﹤0.01%
200
– –
1 2 3
4
5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q1 2018 Portfolio in Review

As of Q1 2018, David M. Knott held 127 positions worth $243M, down 3.5% from $251M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

David M. Knott withdrew a net $21M in Q1 2018, closing 20 positions and reducing 12 holdings. Its most notable exit was Ignyta, Inc., an estimated $1.81M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.

Against the trend, David M. Knott opened a new position in Calumet Specialty Products worth $6.67M.

  • David M. Knott's largest Q1 2018 buy was Calumet Specialty Products: 945,558 shares worth $6.67M.
  • David M. Knott added most to FTAI Aviation in Q1 2018, an estimated $4.2M increase.
  • David M. Knott's biggest Q1 2018 reduction was Ligand Pharmaceuticals, cutting an estimated $33.3M.
  • David M. Knott fully exited Ignyta, Inc. in Q1 2018, selling an estimated $1.81M.
  • David M. Knott's ten largest holdings make up 69% of its $243M portfolio in Q1 2018.
  • David M. Knott opened 18 new positions and closed 20 in Q1 2018.
  • David M. Knott's portfolio value fell 3.5% quarter-over-quarter to $243M.

Based on David M. Knott's 13F filing for Q1 2018, filed 11 May 2018.